• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

Dedication These guidelines are dedicated to Paola De Rango, University of Perugia, Italy.
She participated very actively in the process of developing these guidelines, in particular the …

The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …

Abstract SARS2‐CoV‐2 breakout in Italy caused a huge number of severely ill patients with
a serious increase in mortality. Although lungs seem to be the main target of the infection …

Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …

Vascular disorders of the liver, although affecting less than 5/10,000 patients, collectively
account for a number of rare conditions that represent an important health problem …

Portal hypertension in the absence of portal vein thrombosis and without cirrhosis, but with
mild or moderate alterations of liver histology (eg, obliterative venopathy, nodular …

The present version of the American Association for the Study of Liver Diseases (AASLD)
Position Paper represents a thorough overhaul from the previous version of 2005. In …

Gastroesophageal varices are present at diagnosis in almost half of patients with cirrhosis,
and variceal hemorrhage continues to be a lethal complication of cirrhosis. This review …

Hepatic sinusoidal obstruction syndrome (SOS) is an obliterative venulitis of the terminal
hepatic venules, which in its more severe forms imparts a high risk of mortality. SOS, also …